T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson’s disease (PD), according to a Northwestern Medicine study published in Science. This autoimmune response proves harmful, and inhibiting signaling pathways that trigger the response may represent a future therapeutic target, according